4-PBA (Johns Hopkins)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name4-PBA (Johns Hopkins)
Drug Alias Namesodium 4-phenylbutyratesodium 4-phenylbutyrate (Johns Hopkins)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsSolid tumoursCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A